Trial · NCT00094302
Outcomes25
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 20 of 25
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Composite Outcome of Cardiovascular Mortality, Aborted Cardiac Arrest, or Hospitalization for the Management of Heart Failure, Whichever Occurred First | Randomization through each subject's last semi-annual visit, up to a maximum of 6 years per subject. | All Participants who were randomized were included in the analysis. The analysis was Intention to Treat, meaning all participants were analyzed based on their initial treatment assignment and not on the treatment eventually received. | Events per 100 person-years | NUMBER |
| SECONDARY | Cardiovascular Mortality | Randomization through each subject's last semi-annual visit, up to a maximum of 6 years per subject. | All Participants who were randomized were included in the analysis. The analysis was Intention to Treat, meaning all participants were analyzed based on their initial treatment assignment and not on the treatment eventually received. | Events per 100 person-years | NUMBER |
| SECONDARY | Aborted Cardiac Arrest | Randomization through each subject's last semi-annual visit, up to a maximum of 6 years per subject. | All Participants who were randomized were included in the analysis. The analysis was Intention to Treat, meaning all participants were analyzed based on their initial treatment assignment and not on the treatment eventually received. | Events per 100 person-years | NUMBER |
| SECONDARY | Hospitalization for the Management of Heart Failure | Randomization through each subject's last semi-annual visit, up to a maximum of 6 years per subject. | All Participants who were randomized were included in the analysis. The analysis was Intention to Treat, meaning all participants were analyzed based on their initial treatment assignment and not on the treatment eventually received. | Events per 100 person-years | NUMBER |
| SECONDARY | All-cause Mortality | Randomization through each subject's last semi-annual visit, up to a maximum of 6 years per subject. | All Participants who were randomized were included in the analysis. The analysis was Intention to Treat, meaning all participants were analyzed based on their initial treatment assignment and not on the treatment eventually received. | Events per 100 person-years | NUMBER |
| SECONDARY | Composite Outcome of Cardiovascular Mortality or Cardiovascular-related Hospitalization (i.e., Hospitalization for Myocardial Infarction(MI), Stroke, or the Management of Heart Failure), Whichever Occurred First | Randomization through each subject's last semi-annual visit, up to a maximum of 6 years per subject. | All Participants who were randomized were included in the analysis. The analysis was Intention to Treat, meaning all participants were analyzed based on their initial treatment assignment and not on the treatment eventually received. | Events per 100 person-years | NUMBER |
| SECONDARY | Cardiovascular-related Hospitalization | Randomization through each subject's last semi-annual visit, up to a maximum of 6 years per subject. | All Participants who were randomized were included in the analysis. The analysis was Intention to Treat, meaning all participants were analyzed based on their initial treatment assignment and not on the treatment eventually received. | Events per 100 person-years | NUMBER |
| SECONDARY | Total Hospitalizations (Including Repeat Hospitalizations) for the Management of Heart Failure | Randomization through each subject's last semi-annual visit, up to a maximum of 6 years per subject. | All Participants who were randomized were included in the analysis. The analysis was Intention to Treat, meaning all participants were analyzed based on their initial treatment assignment and not on the treatment eventually received. | Events per 100 person-years | NUMBER |
| SECONDARY | Composite Outcome of Sudden Death or Aborted Cardiac Arrest, Whichever Occurred First | Randomization through each subject's last semi-annual visit, up to a maximum of 6 years per subject. | All Participants who were randomized were included in the analysis. The analysis was Intention to Treat, meaning all participants were analyzed based on their initial treatment assignment and not on the treatment eventually received. | Events per 100 person-years | NUMBER |
| SECONDARY | New Onset Diabetes Mellitus, Among Subjects Without a History of Diabetes Mellitus at Baseline. | Randomization through each subject's last semi-annual visit, up to a maximum of 6 years per subject. | All Participants who were randomized and did not have a history of diabetes mellitus at baseline were included in the analysis. The analysis was Intention to Treat, meaning all participants were analyzed based on their initial treatment assignment and not on the treatment eventually received. | Events per 100 person-years | NUMBER |
| SECONDARY | Development of Atrial Fibrillation, Among Subjects Without a History of Atrial Fibrillation at Baseline. | Randomization through each subject's last semi-annual visit, up to a maximum of 6 years per subject. | All Participants who were randomized and did not have a history of atrial fibrillation at baseline were included in the analysis. The analysis was Intention to Treat, meaning all participants were analyzed based on their initial treatment assignment and not on the treatment eventually received. | Events per 100 person-years | NUMBER |
| SECONDARY | Myocardial Infarction | Randomization through each subject's last semi-annual visit, up to a maximum of 6 years per subject. | All Participants who were randomized were included in the analysis. The analysis was Intention to Treat, meaning all participants were analyzed based on their initial treatment assignment and not on the treatment eventually received. | Events per 100 person-years | NUMBER |
| SECONDARY | Stroke | Randomization through each subject's last semi-annual visit, up to a maximum of 6 years per subject. | All Participants who were randomized were included in the analysis. The analysis was Intention to Treat, meaning all participants were analyzed based on their initial treatment assignment and not on the treatment eventually received. | Events per 100 person-years | NUMBER |
| SECONDARY | Deterioration of Renal Function | Randomization through each subject's last semi-annual visit, up to a maximum of 6 years per subject. | All Participants who were randomized were included in the analysis. The analysis was Intention to Treat, meaning all participants were analyzed based on their initial treatment assignment and not on the treatment eventually received. | Events per 100 person-years | NUMBER |
| SECONDARY | Composite Outcome of Sudden Death, Aborted Cardiac Arrest, or Hospitalization for the Management of Ventricular Tachycardia, Whichever Occurred First | Randomization through each subject's last semi-annual visit, up to a maximum of 6 years per subject. | All Participants who were randomized were included in the analysis. The analysis was Intention to Treat, meaning all participants were analyzed based on their initial treatment assignment and not on the treatment eventually received. | Events per 100 person-years | NUMBER |
| SECONDARY | Quality of Life, as Measured by the Kansas City Cardiomyopathy Questionnaire. | Randomization through each subject's last semi-annual visit, up to a maximum of 6 years per subject. | All Participants who were randomized were included in the analysis. The analysis was Intention to Treat, meaning all participants were analyzed based on their initial treatment assignment and not on the treatment eventually received. | units on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | Quality of Life, as Measured by the EuroQOL Visual Analog Scale. | Randomization through each subject's last semi-annual visit, up to a maximum of 6 years per subject. | All Participants who were randomized were included in the analysis. The analysis was Intention to Treat, meaning all participants were analyzed based on their initial treatment assignment and not on the treatment eventually received. | units on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | Quality of Life, as Measured by McMaster Overall Treatment Evaluation Questionnaire. | Randomization through each subject's last semi-annual visit, up to a maximum of 6 years per subject. | All Participants from United States, Canada and Argentina who were randomized were included in the analysis. The analysis was Intention to Treat, meaning all participants were analyzed based on their initial treatment assignment and not on the treatment eventually received. | units on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | Depression Symptoms, as Measured by Patient Health Questionnaire. | Randomization through each subject's last semi-annual visit, up to a maximum of 6 years per subject. | All Participants from the United States and Canada who were randomized were included in the analysis. The analysis was Intention to Treat, meaning all participants were analyzed based on their initial treatment assignment and not on the treatment eventually received. | units on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | Hospitalization for Any Reason | Randomization through each subject's last semi-annual visit, up to a maximum of 6 years per subject. | All Participants who were randomized were included in the analysis. The analysis was Intention to Treat, meaning all participants were analyzed based on their initial treatment assignment and not on the treatment eventually received. | Events per 100 person-years | NUMBER |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00094302/outcomes